Assessing patient adherence to anti-hypertensive drug therapy: Can a structured pharmacist-conducted interview separate the wheat from the chaff?

International Journal of Pharmacy Practice

Volumn 15, Issue 4, 2007, Pages 295-300

  Yusuff, Kazeem B ^a   Alabi, Abdrahman ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONSULTATION; CONTROLLED STUDY; DEMOGRAPHY; DRUG MONITORING; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NIGERIA; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHARMACIST; PHARMACY; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; STRUCTURED INTERVIEW;

EID: 37049021947     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/ijpp.15.4.0007     Document Type: Article

References (47)

1. McMahon S, Peto R, Cutter J et al. Blood pressure, stroke and coronary heart disease. Part 1; prolonged difference in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
2. Kannel WB, Castelli WP, McNamara PM et al. Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med 1996;334:13-18.
3. Neal B, Clark T, McMahon S et al. Blood pressure and the risk of recurrent vascular disease. Am J Hypertens 1998;11:25A.
4. Klagg MJ, Wherton PK, Randall BL et al. Blood pressure and end-stage renal disease in men. N Engl J Med 1996;334:13-18.
5. Akinkugbe OO. Non-communicable diseases, the next epidemic: Nigerians preparedness. Nig J Clin Pract 2000;3:17-42.
6. Manchia J, Sega R, Miles C et al. Blood pressure control in hypertensive population, Lancet 1997;348:454-7.
7. Colhoun HM, Dong W, Poulter NR. Blood pressure screening, management and control in England: results from the health survey for England 1994. J Hypertens 1998;16:747-52.
8. Oparil S,Calhoun DA. Managing the patient with hard-to-control hypertension. Am Fam Physician 1998;57:100-14.
9. Collins R, Peto R, MacMahon S et al. Blood pressure, stroke and coronary heart disease. Part 2, short-term reduction in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990;335:827-39.
10. MacMahon S, Rodgers A. The effects of anti-hypertensive treatment of vascular disease: reappraisal of the evidence in 1994. J Vasc Med Biol 1993;4:265-71.
11. Costs JB, Davis BR, Cutler J et al, for the SHEP Cooperative Research Group. Prevention of heart failure by anti-hypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1997;278:212-16.
12. Waeber B, Burner M, Brunner HR. Compliance with anti-hypertensive therapy. Clin Exp Hypertens1999;5:973-85.
13. Rapi J. Hypertension therapy and patient compliance. Orv Hetil 2002;143:1979-83.
14. Marro EE, Lwakatare J. Medication compliance among Tanzanian hypertensives. East Afr Med J 1997;74:539-42.
15. Schoberberger MJ, Pescosta W, Sonneck G. The Compliance Praxis Survey (COMPASS): a multidimensional instrument to monitor compliance for patients on antihypertensive medication. J Hum Hypertens 2002;16:779-87.
16. Salako BL, Ayodele OE. Observable factors responsible for resistant hypertension in a teaching hospital setting. Afr J Med Med Sci 2003;32:151-4.
17. Ross S, Walker A, MacLeod MJ. Patient compliance in hypertension: role of illness perceptions and treatment beliefs. J Hum Hypertens 2004;18:607-13.
18. Bourgault C, Sénécal M, Brisson M, Marentette MA, Grégoire JP. Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study. J Hum Hypertens 2005;19:607-13.
19. Khalil SA, Elzubier AG. Drug compliance and among hypertensive patients in Tabuk, Saudi Arabia. J Hypertens 1997;15:561-5.
20. Ogunyemi O. Reasons for failure of anti-hypertensive treatment. BMJ 1983;286:1956-7.
21. Kaufman JS, Rotimi CN, Brieger WR et al. The mortality risk associated with hypertension: preliminary results of a prospective study in rural Nigeria. J Hum Hypertens 1996;10:461-4.
22. Amakiri CN, Akang EE, Aghadiuno PU et al. A prospective study of coroner's autopsies in University College Hospital, Ibadan, Nigeria. Med Sci Law 1997;37:67-75.
23. Kadiri S, Olutade BO, Osobamiro O. Factors influencing the developmentof malignant hypertension in Nigeria. J Hum Hypertens 2000;14:171-4.
24. Isezuo AS, Omotosho ABO, Gaye A et al. One year survival among sub-saharan Africans with hypertensive heart failure. Trop Cardiol 2000;26:57-60.
25. Yusuff KB, Balogun OB. Physicians' prescribing of anti-hypertensive combinations in a tertiary care setting in southwestern Nigeria. J Pharm Pharm Sci 2005;8:235-42.
26. Yusuff KB, Balogun OB. Pattern of drug utilisation among hypertensive patients in a Nigeria teaching hospital. Pharmacoepidemiol Drug Saf 2005;14:69-74.
27. Lenon C, Hughes CM, Johnston GD, McElnay JC. Identification of psychological factors which influence patient adherence with antihypertensive medication. Int J Pharm Pract 2001;9:R8.
28. Berthoet N, Favrat B, Fallab-Stubi CL, Brunner HR, Burnier M. Why objective monitoring of compliance is important in management of hypertension. J Clin Hypertens 2000;2:210-14.
29. Guerrero D, Rudd P, Bryant-Kosling C, Middleton BF. Antihypertensive medication-taking. Investigation of a simple regimen. Am J Hypertens 1993;6:586-92.
30. Whelton PK. Epidemiology of hypertension. Lancet 1994;344:101-106.
31. Olubodun JO, Falase AO, Cole TO. Drug compliance in hypertensive Nigerians with or without heart failure. Int J Cardiol 1990;27:229-34.
32. Buabeng OK, Matowe L, Plange-Rhule J. Unaffaordable drug prices: the major cause of non-compliance with hypertension medication in Ghana. J Pharm Pharm Sci 2004;7:350-2.
33. United Nation Development Programme (UNDP). Eye of the needle - Nigeria. New York: Human Development Reports; 2000.
34. Youssef RM, Muobarak II. Patterns and determinants of treatment compliance among hypertensive patients. East Mediterr Health J 2002;8:579-92.
35. Miguel JM, Magalhaes F, De Oliveira AG. The effects of adverse effects of antihypertensive therapy: the perception of patients. Rev Portuguesa de Cardiol 1999;18:123-30.
36. Balazovjech I, Hnilica P Jr. Compliance with antihypertensive treatment in consultation rooms for hypertensive patients. J Hum Hypertens 1993;7:581-3.
37. Ludin AP. Causes of noncompliance in dialysis patients. E-NEPH Archive. Dial Transplant 1995;24:174.
38. Morisky DE, Levine DM, Green LW et al. Five year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health 1983;73:153-62.
39. Ashida T, Sugiyama T, Okuno S et al. Relationship between home blood pressure measurement and medication compliance and name recognition of anti-hypertensive drugs. Hypertens Res 2000;23:21-4.
40. Vetter W, Hess L, Brignoli R. Influence of self-measurement of blood pressure on the responder rate in hypertensive patients treated with Losartan: results of the SVATCH Study. J Hum Hypertens 2000;14:235-41.
41. Olubodun JO. Physicians' approach to management of hypertension in a developing community. Int J Cardiol 1995;51:193-7.
42. Ndom RJ, Makanjuola AB. Perceived stress factors among resident doctors in a Nigerian teaching hospital. West Afr J Med 2004;23:78-81.
43. Talabi OA. A questionnaire survey of senior house officers/registrars response to their training at University College Hospital. West Afr J Med 2003;22:108-11.
44. Jameson JP, VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother 2001;35:835-40.
45. Bond CA, Raehl CL, Franke T. Clinical pharmacy services, hospital pharmacy staffing and medication errors in United States hospitals. Pharmacotherapy 2002;22:134-47.
46. Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health-Syst Pharm 2002;59:2089-92.
47. Fodor GJ, Kotrec M, BacsKai K et al. Is interview a reliable method to verify compliance with antihypertensive therapy? An international central-European study. J Hum Hypertens 2005;23:1261-6.